Autor der Publikation

Equitoxicity of bolus and infusional etoposide: results of a multicenter randomised trial of the German High-Grade Non-Hodgkins Lymphoma Study Group (DSHNHL) in elderly patients with refractory or relapsing aggressive non-Hodgkin lymphoma using the CEMP regimen (cisplatinum, etoposide, mitoxantrone and prednisone)

, , , , , , , , , , , und . Annals of hematology, 87 (9): 717–726 (2008)

Bitte wählen Sie eine Person um die Publikation zuzuordnen

Um zwischen Personen mit demselben Namen zu unterscheiden, wird der akademische Grad und der Titel einer wichtigen Publikation angezeigt. Zudem lassen sich über den Button neben dem Namen einige der Person bereits zugeordnete Publikationen anzeigen.

 

Weitere Publikationen von Autoren mit dem selben Namen

The role of sex and weight on rituximab clearance and serum elimination half-life in elderly patients with DLBCL, , , , , , , , , und 5 andere Autor(en). Blood, 119 (14): 3276–3284 (2012)Favorable impact of the interleukin-4 receptor allelic variant I75 on the survival of diffuse large B-cell lymphoma patients demonstrated in a large prospective clinical trial, , , , , , , , und . Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 20 (9): 1548–1554 (2009)Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin's lymphoma: II. Results of the randomized high-CHOEP trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL), , , , , , , , , und 5 andere Autor(en). Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 19 (3): 545–552 (2008)CNS disease in younger patients with aggressive B-cell lymphoma: an analysis of patients treated on the Mabthera International Trial and trials of the German High-Grade Non-Hodgkin Lymphoma Study Group, , , , , , , , , und . Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 23 (5): 1267–1273 (2012)Comparison and modelling of pegylated or unpegylated G-CSF schedules in CHOP-14 regimen of elderly patients with aggressive B-cell lymphoma, , , , , , und . Annals of hematology, 92 (12): 1641–1652 (2013)Structural aberrations affecting the MYC locus indicate a poor prognosis independent of clinical risk factors in diffuse large B-cell lymphomas treated within randomized trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL), , , , , , , , , und . Leukemia, 22 (12): 2226–2229 (2008)Risk factors for bleeding complications after endoscopic variceal ligation therapy, , , , , und . Zeitschrift für Gastroenterologie, 48 (10): 1200–1206 (2010)Randomized comparison of pegfilgrastim day 4 versus day 2 for the prevention of chemotherapy-induced leukocytopenia, , , , , , , , , und 3 andere Autor(en). Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 22 (8): 1872–1877 (2011)Effect of interleukin-10 gene polymorphisms on clinical outcome of patients with aggressive non-Hodgkin's lymphoma: an exploratory study, , , , , , , , , und 3 andere Autor(en). Clinical cancer research : an official journal of the American Association for Cancer Research, 14 (12): 3777–3784 (2008)Incidence and risk factors of central nervous system recurrence in aggressive lymphoma--a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL), , , , , , und . Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 18 (1): 149–157 (2007)